...ycler holds 96 x 0.2 ml tubes or a 96-well micropl...el to adjust height and pressure to tightly seal P...s produce uniform, accurate temperatures with NIST...1.4 degrees C per second. Cycler comes with 8 prep...
...ermocycler provides maximum performance on minimum...ents, high heating and cooling rates have been ach...imum capacity of 48 x 0.2ml tubes, the Tpersonal p...6 well instruments. Alternatively, the instrument ...
Dual-bay Dyad thermal cycler chassis from Bio-Rad
Artisan™ Wash Solution (x 50) from Dako
Biology Products:(Date:11/24/2009)...NMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neurog...ocusedondevelopingandcommercializingnovelpainmanag...esidentandChiefExecutiveOfficer,isscheduledtoprese...tobeheldDecember1-2,2009atTheNewYorkPalaceHotelinN...i,ChiefFinancialOfficer,willbeavailabletorespondto...
(Date:11/24/2009)...imaryefficacyendpointhasbeenmetforpatientswithadva...EBECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZenta...albiopharmaceuticalcompanyfocusedonendocrinetherap...maPhase2studywithitstargetedcytotoxicpeptideconjug...dorrecurrentendometrialcancer.Inapersonalizedhealt...
(Date:11/24/2009)...DWOODCITY,Calif.,Nov.24/PRNewswire-FirstCall/--Gen...ndyScott,GenomicHealth,sExecutiveChairman,willpres...inNewYorkCityonTuesday,December1,2009at10:00a.m.ET...astofthepresentation,visittheInvestorRelationssect...michealth.com .Pleaseconnecttothewebsiteatleast15m...
(Date:11/24/2009)...ATTLE,Nov.24/PRNewswire-FirstCall/--CellTherapeuti...ntatthe21stAnnualPiperJaffrayHealthCareConference....rkPalaceHotel. ,, CTIwillpresentonTuesday,Decem...eaudiowebcastofCTI,spresentationwillbeavailableat ...forreplayafterwards. , ,PiperJaffrayHealthCareCon...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2